More Confidence to Try Nivolumab and Ipilimumab Combo in Previously Treated Patients

More Confidence to Try Nivolumab and Ipilimumab Combo in Previously Treated Patients

User Photo
AnnualMeeting-SITC2017

3 years
505 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Claire Friedman, MD of Memorial-Sloan Kettering advises healthcare professionals to use Nivolumab and Ipilimumab in treating patients with advanced melanoma, especially since there is a 20% response rate. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
Up Next Autoplay
User Photo